Article | Open | Published:

Activation of the mitochondrial unfolded protein response promotes longevity and dopamine neuron survival in Parkinson’s disease models

Scientific Reportsvolume 7, Article number: 16441 (2017) | Download Citation

Abstract

While the pathogenesis of Parkinson’s disease (PD) is incompletely understood, mitochondrial dysfunction is thought to play a crucial role in disease pathogenesis. Here, we examined the relationship between mitochondrial function and dopamine neuron dysfunction and death using C. elegans mutants for three mitochondria-related genes implicated in monogenic PD (pdr-1/PRKN, pink-1/PINK1 and djr-1.1/DJ-1). We found that pdr-1 and pink-1 mutants exhibit deficits in dopamine-dependent behaviors, but no loss of dopamine neurons, while djr-1.1 mutants showed an increased sensitivity to oxidative stress. In examining mitochondrial morphology and function, we found that djr-1.1 mutants exhibit increased mitochondrial fragmentation leading to decreased rate of oxidative phosphorylation and ATP levels. pdr-1 and pink-1 mutants show an accumulation of dysfunctional mitochondria with age, which leads to activation of the mitochondrial unfolded protein response (mitoUPR). Preventing the upregulation of the mitoUPR with a deletion in atfs-1 results in decreased lifespan and dopamine neuronal loss in pdr-1 and pink-1 mutants but not in wild-type worms. Overall, our results suggest that mutations in pdr-1 and pink-1 cause the accumulation of dysfunctional mitochondria, which activates the mitoUPR to mitigate the detrimental effect of these mutations on dopamine neuron survival.

Introduction

Parkinson’s disease (PD) is the second most common neurodegenerative disease currently affecting as many as 10 million individuals worldwide. Clinically, PD is characterized by deficiencies in movement including bradykinesia, postural instability, resting tremor, rigidity, and a shuffling gait that become progressively worse through the course of disease. Patients also typically experience non-motor symptoms such as dementia, sleep disturbances, and depression. In the brain, PD patients exhibit the loss of dopamine neurons in the substantia nigra (SN), which is part of the basal ganglia. At the cellular level, neurons show accumulation of α-synuclein-containing protein aggregates known as Lewy Bodies.

While the pathogenesis of PD is incompletely understood, accumulating evidence suggests that mitochondrial dysfunction is a crucial step in disease pathogenesis. First, PD patients exhibit deficits in mitochondrial electron transport chain function1. Second, it has been shown that toxins that affect mitochondrial function, such as MPTP or rotenone, can selectively kill dopamine neurons2,3. As a result, these mitochondrial toxins have been used to model PD4. Third, genes involved in mitochondrial function have been shown to cause monogenic forms of PD, including PRKN, PINK1 and DJ-1 5,6,7,8,9.

Parkin, encoded by PRKN in humans and pdr-1 in C. elegans, is a component of the E3 ubiquitin ligase multiprotein complex that tags proteins for degradation in the ubiquitin-proteasome system. Under normal conditions, Parkin resides in the cytoplasm and ubiquitinates a wide variety of cytosolic targets10,11. However, under conditions of mitochondrial stress, Parkin can move to the mitochondria to target mitochondrial outer membrane proteins12. Notably, Parkin has been shown to work with PINK1 (PTEN-induced putative kinase 1) to control mitophagy, the process by which damaged mitochondria are degraded13,14.

PINK1, which is encoded by pink-1 in C. elegans, is a kinase that is localized to the mitochondria. While PINK1 is degraded under normal conditions, when the mitochondrial membrane becomes depolarized due to stress, the degradation of PINK1 is prevented thereby allowing PINK1 to recruit the cellular machinery necessary to recycle defective mitochondria15,16. PINK1, the first known ubiquitin-kinase, recruits autophagy receptors, expediting the ability of Parkin to tag defective mitochondria with ubiquitin to initiate mitophagy17.

DJ-1 is a highly conserved protein5 that has been proposed to play a role in oxidative stress as a redox-sensitive chaperone18,19,20. The protein product of DJ-1 is a deglycase that has been found to localize to the mitochondria21. In C. elegans, DJ-1 is encoded by the djr-1.1 and djr-1.2 homologs, which have been shown to be primarily expressed in the intestine and in neurons, respectively22. Interestingly, DJ-1 has been shown to interact with parkin and PINK1 to promote protein degradation23.

In this work, we provide a thorough characterization of C. elegans models with deletions in mitochondrial-related genes that have been implicated in PD, and explore the relationship between mitochondrial function and phenotypic deficits. We find that pdr-1, pink-1 and djr-1.1 deletion mutants all exhibit mild phenotypes despite clear deficits in mitochondrial function. Our results suggest that there is an accumulation of dysfunctional mitochondria in pdr-1 and pink-1 mutants that leads to the activation of the mitochondrial unfolded protein response (mitoUPR). This response mitigates the detrimental effects of the PD mutations and protects against the loss of dopamine neurons.

Results

pdr-1 and pink-1 mutants display deficits in dopamine-dependent behaviors in absence of neurodegeneration

To determine whether mutations in mitochondria-related genes that have been implicated in PD cause quantifiable deficits that could be used as outcome measures to identify disease modifiers, we characterized measures of general health and dopamine-dependent behavior in pdr-1, pink-1 and djr-1.1 worms. All three strains are deletion mutants thereby modeling the loss of function mutations present in the human disease. We found that lifespan was not decreased in any of the PD mutants (Fig. 1a). Decreased fertility, slow post-embryonic development time or a slow defecation cycle length can be indications that a worm is unhealthy. We found that fertility, as measured by brood size, is decreased in djr-1.1 mutants (Fig. 1b), while pink-1 mutants exhibit slow post-embryonic development (Fig. 1c). All three mutants exhibited a normal rate of defecation (Fig. 1d).

Figure 1
Figure 1

p dr-1 and pink-1 mutants exhibit deficits in dopamine-dependent behaviors. (a) Lifespan is not decreased in pdr-1, pink-1 or djr-1.1 mutants. (b) Fertility, as measured by self-brood size, is decreased in djr-1.1 worms. (c) pink-1 mutants develop significantly slower than wild-type worms. (d) Defecation cycle length is not affected in any of the mutants. (e) Movement in liquid (thrashing) is also unaffected. (f) pdr-1 mutants show a mild deficit in crawling speed on solid plates. (g) All three mutants exhibit a trend towards decreased ethanol avoidance, which only reaches significance in pdr-1 mutants. (h) Both pdr-1 and pink-1 mutants have a deficit in basal slowing. (i) Despite showing deficits in dopamine-dependent behaviors there is no evidence for neuronal loss in pdr-1, pink-1 or djr-1.1 mutants. This indicates that the deficits in dopamine-dependent behavior results from neuronal dysfunction, not neuronal loss. Error bars indicate SEM. *p < 0.05, ***p < 0.001.

Next, we sought to determine if the PD mutations would affect movement, as this is a key feature of the human disease. Movement was assessed both in liquid, by determining the thrashing rate, and on solid plates by measuring crawling speed. In both cases, movement was assessed in an unbiased manner using video-tracking and computer analysis. We found that all of the PD mutants have a normal thrashing rate (Fig. 1e) and that pdr-1 mutants have a mild movement deficit in crawling (Fig. 1f).

Finally, we tested behaviors that have previously been shown to be dependent on intact dopaminergic signaling, including ethanol avoidance and basal slowing. First, we verified that these behaviors are dopamine-dependent and absent in dopamine-depleted cat-2 tyrosine hydroxylase mutants (Supplementary Fig. S1). In testing the PD mutants, we found that all three strains showed a trend towards decreased ethanol avoidance behavior, but the difference only reached significance in pdr-1 worms (Fig. 1g). In the basal slowing assay, both pdr-1 and pink-1 worms showed a significant deficit in slowing (Fig. 1h).

In order to determine whether the change in dopamine-dependent behavior is caused by a loss of dopamine neurons, we crossed pdr-1, pink-1 and djr-1.1 worms to worms expressing GFP under the dopamine-specific dat-1 promoter such that we could visualize neurons in vivo throughout the animal’s lifespan. We found that even at day fifteen of adulthood these mutant strains exhibit no loss of dopamine neurons (Fig. 1i). This suggests that the deficit in dopamine-dependent behaviors in pdr-1 and pink-1 mutants is caused by neuronal dysfunction, not neuronal death.

As a significant deficit in dopamine-dependent behavior was not observed in djr-1.1 worms, we hypothesized that this may be due to the presence of djr-1.2, which is primarily expressed in neurons22. Accordingly, we characterized djr-1.2 and djr-1.1;djr-1.2 worms. As with djr-1.1 worms, we did not observe a significant deficit in basal slowing or any evidence of dopamine neuron loss in either strain (Supplementary Fig. S2).

pdr-1 and pink-1 mutants accumulate dysfunctional mitochondria with age

Having observed deficits in dopamine-dependent behavior, we next sought to determine whether these deficits were associated with alterations in mitochondrial form and function. To visualize mitochondrial morphology we utilized a fluorescent reporter strain in which GFP is targeted to the mitochondrial matrix of body wall muscle cells (P myo-3 ::mitoGFP)24. Images of mitochondria were collected at day 1 and day 7 of adulthood and quantified. In wild-type worms, mitochondria in the body wall muscle exhibit a very regular pattern consisting of many parallel tracts of elongated mitochondria (Fig. 2a). This pattern is maintained at day 7 of adulthood, although total mitochondrial content is decreased. In contrast, pdr-1 worms exhibit less tubular mitochondria (increased circularity Fig. 2b) and have an increased abundance of mitochondria compared to wild-type worms (Fig. 2c,d), indicating that pdr-1 worms accumulate mitochondria with age. As a control for increased mitochondrial fragmentation, we examined mitochondrial morphology in fzo-1 worms, which have a deletion mutation that disrupts the outer mitochondrial membrane fusion protein FZO-1. As expected, these worms exhibit fragmented mitochondria at day 1 of adulthood and these mitochondria have increased circularity (Supplementary Fig. S3).

Figure 2
Figure 2

pdr-1 mutants show an accumulation of dysfunctional mitochondria with age. (a) Mitochondria in pdr-1 mutants exhibit abnormal morphology. (b) Quantification of mitochondrial shape reveals a significant increase in circularity in pdr-1 mitochondria compared to wild-type. (c) pdr-1 mutants also show a marked increase in mitochondrial number. (d) pdr-1 mutants show an accumulation of mitochondria with age as indicated by increased mitochondrial content. The increase in mitochondrial content results in an increase in oxygen consumption (e), but a decrease in ATP levels (f). Error bars indicate SEM. *p < 0.05, **p < 0.01, ***p < 0.001.

We then asked how the observed differences in mitochondrial morphology affect mitochondrial function by measuring the rate of oxidative phosphorylation and ATP levels. It has previously been shown that a more highly fused mitochondrial network can be more efficient at generating ATP25,26. The rate of oxidative phosphorylation was determined by measuring oxygen consumption using a Seahorse extracellular flux analyzer, while ATP levels were measured utilizing a luciferin-based assay. We found that pdr-1 mutants exhibit increased oxygen consumption (Fig. 2e) and decreased ATP levels (Fig. 2f) compared to wild-type worms. The increase in oxygen consumption is consistent with the mitochondrial accumulation observed in pdr-1 worms. The fact that ATP levels are decreased, despite an increased rate of oxidative phosphorylation, suggests that pdr-1 mutants are accumulating dysfunctional mitochondria, and is consistent with the known role of Parkin in mitophagy.

As with pdr-1 mutants, we found that mitochondria in pink-1 worms exhibit an accumulation of mitochondria with increasing age (Fig. 3a,c,d). However, in contrast to pdr-1 worms, the shape of pink-1 mitochondria was not different from wild-type (Fig. 3b). Measurement of oxygen consumption revealed that although pink-1 worms show a similar increase in mitochondrial content to pdr-1 worms, these worms maintain a normal rate of oxygen consumption (Fig. 3e). This indicates that mitochondrial mass does not necessarily predict oxygen consumption. Similarly, pink-1 worms were found to have normal levels of ATP (Fig. 3f). Since pink-1 worms have more mitochondria than wild-type worms, this indicates that oxygen consumption and ATP production per mitochondria are both decreased in pink-1 worms, suggesting that like pdr-1 mutants, pink-1 worms also accumulate dysfunctional mitochondria.

Figure 3
Figure 3

pink-1 mutants show an accumulation of mitochondria with age. (a) Mitochondria in pink-1 mutants exhibit abnormal morphology especially at the aged time point. While there was no difference in mitochondrial shape (b), pink-1 show an increase in mitochondrial abundance with age (c,d). Nonetheless, oxygen consumption (e) and ATP levels (f) do not differ from wild-type worms. This suggests that the mitochondria in pink-1 worms have a reduced rate of oxidative phosphorylation compared to wild-type worms but that the ATP produced per amount of oxygen consumed is not decreased. Error bars indicate SEM. *p < 0.05, **p < 0.01, ***p < 0.001.

djr-1.1 mutants exhibit mitochondrial fragmentation

In contrast to pdr-1 and pink-1 mutants, djr-1.1 worms showed marked differences in mitochondrial morphology on day 1 of adulthood. As previously observed in cell culture models27, we found that djr-1.1 mutants exhibit increased mitochondrial fragmentation. While wild-type worms exhibit elongated, parallel mitochondrial networks, in djr-1.1 mutants spherical mitochondria predominate (Fig. 4a), resulting in a significant increase in mitochondria circularity (Fig. 4b). The increase in mitochondrial fragmentation results in a higher number of mitochondria in djr-1.1 worms compared to wild-type (Fig. 4c) but decreased total mitochondrial content as measured by integrated density of GFP (Fig. 4d). The altered mitochondrial morphology in djr-1.1 mutants also affects mitochondrial function: djr-1.1 mutants have a decreased rate of oxygen consumption (Fig. 4e) and decreased levels of ATP (Fig. 4f).

Figure 4
Figure 4

djr-1.1 mutants exhibit mitochondrial fragmentation. (a) Mitochondria in djr-1.1 mutants show increased fragmentation compared to wild-type worms. Consistent with this observation, the mitochondria in djr-1.1 mutants are more circular than those of wild-type worms (b), and there is an increase in the number of mitochondria at day 7 of adulthood (c). In contrast, total mitochondrial content is increased on day 1 of adulthood (d). Oxygen consumption is decreased at both time points in djr-1.1 mutants (e) leading to decreased levels of ATP (f). Overall, an increase in mitochondrial fragmentation in djr-1.1 mutants results in decreased levels of ATP. Error bars indicate SEM. *p < 0.05, **p < 0.01, ***p < 0.001.

djr-1.1 mutants have increased sensitivity to oxidative stress

Disruptions of mitochondrial function can lead to an over production of reactive oxygen species (ROS), which in turn can cause increased accumulation of oxidative damage and increased sensitivity to oxidative stress. To measure ROS levels in young worms, we stained the PD mutant worms with the ROS-sensitive dye dihydroethidium (DHE), we crossed the PD mutants to a genetically-encoded biosensor for glutathione redox potential (Grx1-roGFP228), and measured protein carbonylation as a measure of oxidative damage. We did not observe any significant differences from wild-type worms in any of the PD mutants (Supplementary Fig. S4a–c). To quantify oxidative damage in aged PD mutants, we measured the levels of lipofuscin, which consists of oxidized proteins and lipids that emit a fluorescent signal, which increases with age29. We found that at day 10 of adulthood pdr-1, pink-1 and djr-1.1 mutants exhibited increased levels of lipofuscin fluorescence compared to wild-type worms, which is consistent with an increase in oxidative damage (Fig. 5a).

Figure 5
Figure 5

pdr-1 and pink-1 mutants exhibit activation of the mitochondrial unfolded protein response (mitoUPR). (a) pdr-1, pink-1 and djr-1.1 mutants all exhibit increased accumulation of lipofuscin, indicating increased levels of oxidative damage. (b) Measuring sensitivity to oxidative stress induced by exposing worms to 2 mM paraquat beginning at day 1 of adulthood revealed that djr-1.1 mutants have increased sensitivity to oxidative stress. Exploring sensitivity to osmotic stress (c) and heat stress (d) showed that pdr-1 mutants have increased sensitivity to both types of stress, while djr-1.1 mutants have increased sensitivity to heat stress. (e,f) Both pdr-1 and pink-1 mutants exhibit activation of the mitoUPR as measured using a Phsp-6::GFP reporter strain. Error bars indicate SEM. **p < 0.01, ***p < 0.001.

To test sensitivity to oxidative stress, worms were exposed to paraquat, a compound which acts to increase intracellular concentrations of superoxide primarily in the mitochondria. We found that on day 1 of adulthood, djr-1.1 worms have increased sensitivity to chronic oxidative stress while pdr-1 and pink-1 worms do not differ from wild-type worms (Fig. 5b). As oxidative stress has been shown to change with age30, we next sought to determine whether pdr-1 and pink-1 mutants develop increased sensitivity to oxidative stress later in life. We examined paraquat sensitivity on day 7 of adulthood and observed a mild increase in sensitivity to oxidative stress in pink-1 worms but not pdr-1 worms compared to wild-type worms (Supplementary Fig. S4d).

To determine whether the PD mutants are sensitive to other forms of stress, we assayed sensitivity to both osmotic and heat stress. Both of these forms of stress induce protein misfolding, which has been associated with PD. Sensitivity to osmotic stress was assayed by exposing worms to NGM plates containing 550 mM NaCl (11X salt concentration in normal NGM plate), while heat stress was induced by incubating the animals at 37 °C. We found that pdr-1 mutants have significantly increased sensitivity to both osmotic stress and heat stress (Fig. 5c,d), pink-1 mutants exhibited a trend towards increased sensitivity to osmotic and heat stress that failed to reach significance (Fig. 5c,d), and djr-1.1 exhibited a trend towards increased sensitivity to osmotic stress and significantly decreased survival under heat stress (Fig. 5c,d).

pdr-1 and pink-1 mutants exhibit activation of the mitochondrial unfolded protein response

Since all three PD mutants showed increased sensitivity to stress, we next sought to determine whether these mutants exhibit activation of stress response pathways. Initially, we examined the mitochondrial unfolded protein response (mitoUPR), which is activated by disruption of protein homeostasis in the mitochondria. Since pdr-1 mutants and pink-1 mutants both accumulate dysfunctional mitochondria with age, we hypothesized that these worms would exhibit activation of the mitoUPR. To measure the activation of the mitoUPR, we crossed the PD mutant strains to a Phsp-6::GFP reporter strain (HSP-6 is a chaperone protein whose expression is upregulated by the mitoUPR)31. We found that the mitoUPR is activated in pdr-1 and pink-1 mutants (Fig. 5e,f).

ATFS-1 is required for the normal longevity of pdr-1 mutants

To determine if the upregulation of the mitoUPR acts to mitigate the detrimental effects of mutations in pdr-1 and pink-1, we examined the effect of blocking the mitoUPR. We crossed pdr-1 and pink-1 mutants with an atfs-1 deletion mutant since the transcription factor ATFS-1 is required for the mitoUPR32. We then compared physiologic rates between the PD mutants in a wild-type or atfs-1 mutant background. Note that we did not examine the effect of atfs-1 deletion in djr-1.1 mutants because we did not observe activation of the mitoUPR in this strain. As a result, for the remaining experiments we focused on the effect of atfs-1 deletion in pdr-1 and pink-1 mutants.

While the atfs-1 mutation did not affect lifespan in wild-type worms, deletion of atfs-1 significantly decreased the lifespan of pdr-1 mutants (Fig. 6a–c). Post-embryonic development time was slowed by the atfs-1 mutation in wild-type, pdr-1 and pink-1 worms (Fig. 6d), but notably there was a significant interaction between pink-1 and atfs-1 as pink-1;atfs-1 worms developed slower than atfs-1 or pink-1 mutants alone. Fertility, as measured by brood size, was decreased by atfs-1 deletion in wild-type, pdr-1 and pink-1 worms (Fig. 6e), but again to the greatest extent in pink-1;atfs-1 double mutants. Deletion of atfs-1 also slowed the defecation rate in all three strains (Fig. 6f). Finally, we found that the rate of movement in liquid (thrashing rate) was significantly decreased in pdr-1;atfs-1 mutants compared to pdr-1 mutants (Fig. 6g), while movement on solid plates was decreased in WT, pdr-1 and pink-1 mutants by the loss of atfs-1 (Fig. 6h). Overall, the loss of atfs-1 affects multiple physiologic rates, and in the case of lifespan, development time, fertility and thrashing it unmasks deficits that are present only in the PD mutant strains.

Figure 6
Figure 6

ATFS-1 is required for the normal lifespan of pdr-1 and pink-1 mutants. While atfs-1 mutants live as long as wild-type worms (a), deletion of atfs-1 decreases the lifespan of pdr-1 mutants (b) but does not significantly decrease the lifespan of pink-1 worms (c). The loss of atfs-1 slows development time (d), decreases fertility (e), and slows the rate of defecation (f) in all backgrounds. The atfs-1 deletion significantly slowed the thrashing rate of pdr-1 mutants (g), and decreased crawling speed in wild-type, pdr-1 and pink-1 worms (h). Error bars indicate SEM. *p < 0.05, **p < 0.01, ***p < 0.001.

Loss of ATFS-1 disrupts mitochondrial function and increases sensitivity to stress

Having shown that disruption of atfs-1 affects physiologic rates in PD mutants, we next sought to determine the effect on mitochondrial morphology and function. We crossed pdr-1;atfs-1 and pink-1;atfs-1 double mutants to Pmyo-3::mito:GFP worms to visualize mitochondrial morphology. Surprisingly, we found that in an atfs-1 mutant background the mitochondrial matrix-targeted GFP exhibited diffuse cytoplasmic fluorescence (Fig. 7a). To determine whether this resulted from the absence of mitochondria or a mislocalization of the mitochondria-targeted GFP, we stained worms with the mitochondria specific dye tetramethylrhodamine ethyl ester (TMRE). TMRE successfully delineated the mitochondria in the atfs-1 mutant background (Fig. 7b). This suggests that the atfs-1 mutant causes mislocalization of the mitochondria-matrix targeted GFP. Examination of mitochondrial function revealed that the atfs-1 mutation caused a decrease in oxygen consumption in wild-type, pdr-1 and pink-1 worms (Fig. 7c), however it did not significantly alter ATP levels (Fig. 7d).

Figure 7
Figure 7

Loss of atfs-1 causes mislocalization of mitochondrially-targeted GFP and disrupts mitochondrial function. (a) To examine mitochondrial morphology we crossed the atfs-1 mutant strains to worms with mitochondrial matrix targeted GFP. We found that the loss of atfs-1 disrupted the mitochondrial localization of the GFP resulting in diffuse fluorescence throughout the cytoplasm. (b) Staining mitochondria with TMRE confirms that the lack of GFP localization to mitochondria in atfs-1 deletion mutant background does not result from the absence of mitochondria. Deletion of atfs-1 resulted in decreased oxygen consumption in all backgrounds (c) but did not significantly affect the levels of ATP (d) Error bars indicate SEM. ***p < 0.001.

Next, we examined the effect of the atfs-1 mutation on resistance to stress in the PD mutant strains. We found that deletion of atfs-1 increased sensitivity to 3 mM paraquat oxidative stress (Fig. 8a), 550 mM NaCl osmotic stress (Fig. 8b), 37 °C heat stress (Fig. 8c), and anoxia (Fig. 8d). Interestingly, although loss of atfs-1 affected oxidative stress, osmotic stress, and heat stress similarly in the PD mutants and wild-type worms, it only increased sensitivity to anoxia in the PD mutants.

Figure 8
Figure 8

The mitoUPR is required for the survival of dopamine neurons in pdr-1 and pink-1 mutants. Deletion of atfs-1 results in increased sensitivity to oxidative stress (3 mM paraquat, a) osmotic stress (550 mM NaCl, b) heat stress (37 °C, c) and anoxia (d) The loss of atfs-1 does not exacerbate deficits in ethanol avoidance (e) or basal slowing (f) in the Parkinson’s disease mutants, but did induce a basal slowing deficit in wild-type worms. (g) Deletion of atfs-1 does not decrease the survival of dopamine neurons in wild-type worms. (h) pdr-1;atfs-1 double mutants exhibit a trend towards decreased numbers of dopamine neurons compared to pdr-1 mutants. (i) Loss of atfs-1 accelerated dopamine neuronal loss in pink-1 mutants. Error bars indicate SEM. *p < 0.05, **p < 0.01, ***p < 0.001.

Activation of the mitoUPR protects dopamine neurons from death

Finally, we determined the effect of blocking the mitoUPR on PD-like deficits in pdr-1 and pink-1 mutants. There was no effect of the atfs-1 deletion on ethanol avoidance (Fig. 8e); however, it should be noted that we observed increased clumping behavior in worms with the atfs-1 deletion, which could have impacted the outcome of this assay. In the basal slowing assay, the atfs-1 mutation caused a significant deficit in basal slowing in a wild-type background, but did not further exacerbate basal slowing deficits present in pdr-1 and pink-1 worms (Fig. 8f). Quantification of dopamine neuron loss showed that loss of atfs-1 did not affect neuronal survival in a wild-type background (Fig. 8g). pdr-1;atfs-1 mutants show a trend towards increased dopamine neuron loss compared to pdr-1 single mutants (Fig. 8h). pink-1;atfs-1 worms had a significantly increased rate of dopamine neuron loss compared to wild-type, atfs-1 or pink-1 worms (Fig. 8i). This indicates that the ability to activate the mitoUPR is required for dopamine neuron survival in pink-1 PD mutants and that the mitoUPR can be neuroprotective in genetic models of PD.

Discussion

In order to identify and test disease modifiers for Parkinson’s disease, it is essential to have accurate animal models with robust phenotypic deficits that are analogous to symptoms present in the human disease. If this can be accomplished in a simple invertebrate organism, it becomes possible to screen for modifiers rapidly and cost-effectively. As yeast do not have homologs to PRKN or PINK1 33, C. elegans represents the simplest genetic model organism with homologs to PRKN, PINK1 and DJ-1. Accordingly, we characterized phenotypic deficits in C. elegans mutants with deletions in each of these mitochondria-associated genes that have been implicated in PD.

pdr-1 mutants have decreased lifespan and increased sensitivity to rotenone34, decreased survival against bacterial pathogens35, increased sensitivity to heat stress and paraquat-induced oxidative stress36, and increased accumulation of manganese, which has been associated with the development of PD37. In addition, pdr-1 RNAi decreases the survival of dopamine neurons in worms expressing α-synuclein in their dopamine neurons38 or in worms expressing LRRK2 treated with rotenone39. Here, we found that the pdr-1 mutation alone is not sufficient to decrease the survival of dopamine neurons. Nonetheless, pdr-1 mutants exhibit deficits in two dopamine-dependent behaviors: ethanol avoidance and basal slowing. This suggests that loss of pdr-1 causes dysfunction of the dopamine neurons but not death.

pink-1 mutants exhibit increased sensitivity to paraquat-induced oxidative stress36,40, heat stress36 and bacterial pathogenicity35. As with pdr-1, knocking down pink-1 using RNAi decreased the survival of dopamine neurons exposed to either α-synuclein or LRRK2 plus rotenone38,39. In this work, we find that pink-1 worms show a significant reduction in basal slowing, but exhibit a wild-type survival of dopamine neurons. Again, this suggests that the deficit in dopamine-dependent behavior in pink-1 worms results from neuronal dysfunction.

Consistent with the role of DJ-1 in sensing and protecting against oxidative stress, djr-1.1 worms have decreased survival compared to wild-type worms when exposed to glyoxals, while djr-1.2 worms exhibit a more rapid loss of dopamine neurons under the same conditions41. DJR-1.2 was also shown to protect dopamine neurons from manganese toxicity22. We found that djr-1.1 mutants exhibit increased sensitivity to paraquat induced oxidative stress, but do not show any significant deficits in dopamine-dependent behavior. In addition, under unstressed conditions, neither djr-1.1 nor djr-1.2 mutants exhibit decreased survival of dopamine neurons.

Combined our results indicate that disruption of mitochondria-associated genes implicated in PD, cause multiple mild phenotypic deficits but no overt neuronal loss. Interestingly, although Parkin, PINK1 and DJ-1 have been shown to act together for specific functions42,43, the fact that we observe different phenotypes in each of the deletion mutants highlights the fact that these proteins also have functions that are independent of the other two proteins.

Parkinson’s disease mutants exhibit age-dependent alterations in mitochondrial morphology and function

In characterizing the three PD mutants, we observed differences in both the form and function of the mitochondria. In djr-1.1 mutants, mitochondrial fragmentation was increased by day 1 of adulthood, leading to the observed decrease in oxygen consumption and lower levels of ATP. Cell culture models of DJ-1 deficiency have also been shown to have an increase in mitochondrial fragmentation27. In pdr-1 and pink-1 mutants, we found that total mitochondrial content was similar to wild-type worms on day 1 of adulthood, but both mutants showed an accumulation of mitochondria with increasing age. pdr-1 and pink-1 mutants were previously shown to exhibit increased mitochondrial content in the intestine36. In addition to increased mitochondrial abundance, pdr-1 and pink-1 worms also showed altered morphology, as has been previously noted36,44. Two previous studies also examined oxygen consumption with differing results: one found that oxygen consumption was wild-type in both mutants44, while the other observed increased oxygen consumption36. In agreement with the former study, we observed normal oxygen consumption on day 1 of adulthood. However, similar to the latter study, we found that oxygen consumption is increased in pdr-1 mutants by day 7 of adulthood. Surprisingly, pdr-1 worms showed decreased levels of ATP despite the increased rate of oxidative phosphorylation, suggesting that these mitochondria are dysfunctional. In pink-1 mutants oxygen consumption and ATP levels were still equivalent to wild-type at day 7 of adulthood, despite the increase in mitochondrial content. This indicates that the ATP produced per mitochondria is decreased in pink-1 mutants, which is consistent with previous observations of proton leak in pink-1 mutants44. A reduction in mitochondrial cristae length in pink-1 mutants40 may also contribute to the decreased ability to produce ATP.

While it would have been more informative to examine maximal respiration and ATP-linked respiration in these mutants, these measurements are challenging in whole worms. Nonetheless, it was previously shown that both maximal and ATP-linked oxygen consumption rates are equivalent to wild-type in pdr-1 and pink-1 mutants44. An alternative approach would be to measure these outputs in dissociated primary cells; however, it is unclear to what extent these readings would reflect what is happening in an intact, whole organism.

Activation of the mitochondrial unfolded protein response promotes dopamine neuronal survival

The accumulation of dysfunctional mitochondria with age in pdr-1 and pink-1 mutants resulted in the activation of the mitoUPR. To determine if mitoUPR activation was masking deficits caused by the pdr-1 and pink-1 mutation, we disrupted the mitoUPR using an atfs-1 deletion mutation. Under normal conditions ATFS-1 is imported into the mitochondria and subsequently degraded. However, under conditions of mitochondrial stress, ATFS-1 import efficiency is reduced allowing this protein to build up in the cytosol, where it can be transported into the nucleus and activate the mitoUPR32. We found that disrupting atfs-1 significantly decreased the survival of pdr-1 mutants and accelerated the loss of dopamine neurons in pink-1 worms. In contrast, the loss of atfs-1 did not affect the lifespan or dopamine neuronal survival in wild-type worms. The loss of atfs-1 did not affect ATP levels in any of the mutants, indicating that the effect of this mutation on other phenotypes is not mediated through a decrease in ATP levels. Overall, our results indicate that the activation of the mitoUPR in pdr-1 and pink-1 worms is protecting these mutants from the detrimental effects of the abnormal form and function of the mitochondria.

The presence of mtDNA deletions can activate the mitoUPR45, and both activation of the mitoUPR and deletion of pdr-1 allow for the accumulation of mtDNA bearing a deletion46. In addition, PDR-1 can modulate the degree of heteroplasmy for an mtDNA truncation47, and reducing the levels of PINK-1 decreases the removal of mtDNA damage48. While on the surface, it would seem to be detrimental to increase the amount of damaged mtDNA through the activation of the mitoUPR, the fact that blocking the mitoUPR in pdr-1 and pink-1 mutants has detrimental effects suggests that this is beneficial for organismal and dopamine neuron survival. Further studies will be required to elucidate the precise mechanisms underlying the observed neuroprotection.

Conclusions

Overall our results show that there are multiple mild phenotypic deficits present in pdr-1, pink-1, and djr-1.1 mutants. All three mutants exhibit abnormalities in both mitochondrial form and function: djr-1.1 mutants primarily show mitochondrial fragmentation while pdr-1 and pink-1 mutations exhibit an accumulation of dysfunctional mitochondria. Both pdr-1 and pink-1 mutants show an activation of the mitoUPR, which is neuroprotective and mitigates the detrimental effect of the pdr-1 and pink-1 mutations.

Methods

Strains

N2(WT)

JVR209 cat-2(e1112)

BY250 vtIs7[Pdat-1::GFP(pRB490)]

JVR122 bcIs78[Pmyo-3::mitoGFP]

JVR121 zcIs13[Phsp-6::GFP]

JVR392 dvIs19[Pgst-4::GFP]

JVR043 pdr-1(gk448)

JVR036 pdr-1(gk448); vtIs7[Pdat-1:GFP(pRB490)]

JVR310 pdr-1(gk448); bcIs78[Pmyo-3::mitoGFP]

JVR345 pdr-1(gk448); zcIs13[Phsp-6::GFP]

JVR392 pdr-1(gk448); dvIs19[Pgst-4::GFP]

MQ1775 pink-1(ok3538)

MQ1794 pink-1(ok3538); vtIs7[Pdat-1:GFP(pRB490)]

JVR309 pink-1(ok3538); bcIs78[Pmyo-3::mitoGFP]

JVR346 pink-1(ok3538); zcIs13[Phsp-6::GFP]

JVR391 pink-1(ok3538); dvIs19[Pgst-4::GFP]

JVR066 djr-1.1(tm918)

JVR220 djr-1.1(tm918); vtIs7[Pdat-1::GFP(pRB490)]

JVR311 djr-1.1(tm918); bcIs78[Pmyo-3::mitoGFP]

JVR347 djr-1.1(tm918); zcIs13[Phsp-6::GFP]

JVR394 djr-1.1(tm918); dvIs19[Pgst-4::GFP]

JVR496 djr-1.2 (tm1346)

JVR374 djr-1.2(tm1346); vtIs7[Pdat-1::GFP(pRB490)]

JVR455 atfs-1(gk3094)

JVR481 atfs-1 (gk3094); vtIs7[Pdat-1::GFP(pRB490)]

JVR482 pdr-1(gk448); atfs-1 (gk3094); vtIs7[Pdat-1::GFP(pRB490)]

JVR483 pink-1(ok3538); atfs-1 (gk3094); vtIs7[Pdat-1::GFP(pRB490)]

JVR484 atfs-1 (gk3094); bcIs78[(Pmyo-3::mitoGFP)]

JVR485 pdr-1(gk448); atfs-1 (gk3094); bcIs78[(Pmyo-3::mitoGFP)]

JVR486 pink-1(ok3538); atfs-1 (gk3094); bcIs78[(Pmyo-3::mitoGFP)]

JVR135 jrIs2[Prpl-17::Grx1-roGFP2]

JVR498 pdr-1(gk448); jrIs2[Prpl-17::Grx1-roGFP2]

JVR499 pink-1(ok3538); jrIs2[Prpl-17::Grx1-roGFP2]

JVR500 djr-1.1(tm918); jrIs2[Prpl-17::Grx1-roGFP2]

All strains were maintained at 20 °C on NGM plates seeded with OP50 bacteria. All strains were outcrossed to N2 (wild-type) three to six times to obtain a uniform strain background.

Generation of strains with multiple mutations

Double/triple mutants were generated as previously described49. Homozygosity of fluorescent transgenes was determined by counting 20–30 worms in three consecutive generations to ensure 100% fluorescence.


Physiologic rates

Lifespan

Lifespan was measured on plates containing 25 μM 5-fluoro-2′-deoxyuridine (FUdR) to limit the growth of progeny and minimize the impact of the FUdR on lifespan50. Animals were transferred to fresh plates after 4 days because this concentration of FUdR does not completely prevent the development of progeny to adulthood in the first generation. From this point on, worms were transferred to fresh plates weekly. Viability was assessed every 2 days by gentle prodding. Worms that either had internal hatching of progeny or expulsion of internal organs were not counted as deaths.

Defecation rate

Defecation cycle length was determined by measuring the time between consecutive pBoc contractions in day-1 adult worms with at least 10 worms per replicate. To minimize the effects of ambient laboratory temperature, defecation was measured on water filled chambers that had been incubated at 20 °C and the lids of the plates containing the worms were not removed.

Postembryonic development time

Post-embryonic development (PED) time was measured by transferring eggs to an NGM plate. After 3 h, newly hatched L1 worms (20–30 worms per replicate) were transferred to a new NGM plate. The time from hatching to the young adult transition was measured as the PED time.

Fertility

Brood size was measured by placing individual worms at the L4 stage onto NGM plates followed by daily transfers to new plates for three days. The resulting progeny was allowed to develop to adulthood before counting (5 worms per replicate).

Rate of movement

Thrashing rate was assessed by measuring swimming behavior in liquid using video-tracking and computer analysis. Approximately 50 worms were placed in M9 buffer (22 mM KH2PO4, 34 mM K2HPO4, 86 mM NaCl, 1 mM MgSO4) on a clean NGM plate. Videos were taken with an Allied Vision Tech Stingray F-145 B Firewire Camera (Allied Vision, Exton, PA, USA) at 1024 × 768 resolution, 8-bit using the MATLAB image acquisition toolbox. Analysis was performed using wrMTrck plugin for ImageJ (publically available at http://www.phage.dk/plugins).

Stress resistance assays: Heat stress, Oxidative stress, Osmotic stress, Anoxia

Stress assays were performed in pre-fertile young adult worms as we have previously described51. Sensitivity to heat stress was determined through hourly assessment of survival at 37 °C. Sensitivity to chronic oxidative stress was determined through exposure to plates containing 2–3 mM paraquat (methyl viologen, Sigma) beginning at day-1 of adulthood. Plates also contained 100 µM FUdR to prevent paraquat-induced internal hatching of progeny. Survival was monitored daily until death. Sensitivity to osmotic stress was determined by transferring day 1 adult worms to NGM plates containing 500 mM NaCl. The survival of worms was determined after 24 h. All stress assays were completed on day-1 of adulthood and included a minimum of 30 worms per replicate.

We assessed nematode resistance to low oxygen environments by utilizing the Becton-Dickinson Bio-Bag Environmental Chamber. Anaerobic atmosphere is achieved within the sealed Bio-Bag using a self-contained generator and resazurin indicator made up of an ampule of HCL solution and two gas-generating tablets. The ampule was crushed, and the acid reacted with the tablets resulting in a gas mixture that absorbs oxygen in the presence of palladium. 30–50 animals were moved to freshly seeded NGM plates and placed in the anoxic chamber for 50 hours. Recovery was allowed for 24 hours, at which time the survival percentage was assessed.

Measurement of fluorescent reporter activity

Reporter activity in adult worms was assessed through measurement of whole worm florescence as previously described52. For each biological replicate, 10 animals were paralyzed with 2 mM levamisole, mounted on an NGM plate and fluorescent images were captured using an AVT Stingray F145B camera and VimbaViewer 1.1.2 software. ImageJ was used to measure the average pixel intensity.


Dopamine-dependent behaviors

Basal slowing

Approximately 50 worms at day 3 of adulthood were washed in M9 buffer to remove any residual bacteria. These cleaned animals were then transferred to either unseeded NGM plates or NGM plates seeded with OP50 bacteria covering the entire plate. After 5 min, videos of the entire plate were recorded for 1 min with an Allied Vision Tech Stingray F-504 B Firewire Camera and a Navitar Zoom 7000 lens (Navitar, Tokyo, Japan) using and the MATLAB image acquisition tool. Recordings were processed using the wrMTrck plugin for ImageJ. Basal slowing was calculated as the difference in rate of movement on food versus off food divided by the rate of movement off food. Crawling speed was calculated from data collected from the unseeded “off-food” NGM plate.

Ethanol avoidance assay

Day-1 adult worms were transferred to assay plates, which were divided into four sectional quadrants: two seeded with 150 μl ethanol (applied in 50 μl increments over 1 hour) and the others without. Worms were cleaned in M9 and then plated in minimal liquid in the center of the assay plate and allowed to move for 30 min at which point the entire plate is imaged and the worms are scored for their quadrant of preference. Ethanol avoidance is calculated as:

((number of worms in control quadrants)−(number of worms in ethanol quadrants))/total number of worms.

Measurement of reactive oxygen species

The levels of ROS were determined using the ROS-sensitive dye dihydroethidium (DHE) as described previously53. 50 worms were incubated in 750 µL of 3 µM DHE dissolved in DMSO for 30 minutes while shaking. After washing in M9 buffer (3 time, 10 minutes), worms were allowed to crawl across an empty NGM plate for 15 minutes prior to imaging. As an alternative approach to measuring ROS levels we used a strain expressing the ratiometric biosensor Grx1-roGFP228. We used a Nikon A1r confocal laser scanning microscope mounted upon a Nikon A1R Ti inverted epifluorescence microscope set up and induced excitation using 405 nm and 488 nm solid state lasers. Age synchronized worms expressing Grx1-roGFP2 were paralyzed with 10 mM levamisole and mounted onto a slide with a 1% agar pad. Animals were imaged using a 40 × 0.95 N.A. objective coupled to a single emission filter (525/50 nm) to create a composite 488 nm/405 nm ratio image. Composite ratio images were then analyzed using ImageJ to subtract background and quantify particle number and intensity.

Measurement of oxidative damage

To quantify oxidative damage in young worms, we measured protein carbonylation using an OxyBlot protein oxidation detection kit (Millipore) according to the manufacturer’s instructions, as we have done previously54. To quantify oxidative damage in old worms, we measured lipofuscin levels. Synchronized day 1 adult animals were plated on 25 μM FUdR plates and aged to day 10 of adulthood. Worms were then transferred to a clean 60 mm NGM plate and paralyzed using 2 mM levamisole. Images of 10 whole worms were captured using a Nikon SMZ 1500 dissecting microscope (Tokyo, Japan) with an Allied Vision Tech Stingray F-145 B Firewire Camera using Vimba image acquisition software (Allied Vision, Exton, PA, USA) and the fluorescence was quantified using ImageJ.

Degeneration of dopamine neurons

The degeneration of dopamine neurons was monitored by expressing GFP specifically in dopamine neurons under the dat-1 dopamine transporter promoter. It was previously shown that treatments that cause a loss of GFP-positive neurons cause a corresponding loss of dopamine neuron cell bodies. Synchronized Pdat-1:GFP worms were plated onto 25 μM FUdR agar plates to be observed at increasing ages. At each time point 10–15 worms were mounted onto a 1% agar pad on a glass slide, immobilized using 2 mM levamisole, and enclosed with a coverslip. Imaging of immobilized animals was carried out with an Axioplan 2 inverted fluorescence microscope (Zeiss, Oberkochen, Germany). Quantification of dopamine neurons was done in a blinded manner.

Oxygen consumption measurements

Basal oxygen consumption rate was measured using a Seahorse XFe96 analyzer (Seahorse bioscience Inc., North Billerica, MA, USA). Synchronized worms were aged to the time point of interest and then cleaned in M9. Cleaned nematodes were pipetted in calibrant (at 30–90 worms per well) into a Seahorse 96-well plate. Oxygen consumption was measured six times and rates of respiration were normalized to the number of worms in each individual well. The plate readings were begun within 20 minutes of introduction of the worms into the well. Reading from each well were normalized relative to the number of animals per well. Well probes were hydrated in 175 µL Seahorse calibrant and the machine was allowed to equilibrate to room temperature overnight proceeding this assay to prevent nematode death.

ATP Measurement

Approximately 200 worms were age-synchronized by transferring daily. Worms were collected in de-ionized water, washed, and were freeze-thawed 3 times. The resulting pellet was sonicated in a Bioruptor (Diagenode) with 30 cycles of 30 seconds on, 30 seconds off. The pellet was boiled for 15 minutes to release ATP, then spun at 4 degrees at 11,000 g for 10 minutes. The supernatant was collected and measured using a Molecular Probes ATP determination Kit (Life Technologies). Luminescence was normalized to protein content, which was measured with a Pierce BCA protein determination kit (Thermo Scientific). Statistical analysis was performed using Graphpad software.

Mitochondrial Imaging and quantification of mitochondrial morphology

Worms were crossed to Pmyo-3::mito-GFP worms and age-synchronized. For imaging, worms were transferred to an agar pad mounted on a slide. Worms were subsequently paralyzed with 10 µM levamisole and cover-slipped. Images were captured by confocal microscopy (Nikon A1R Ti) at 60x. A z-stack of 17 images spaced 0.125 µm apart was collected. For the representative images shown in the figures, a maximum image projection was created in Nikon Elements Basic Research (v.4.6) to compress z-stacks into a single image. All imaging conditions were kept the same for all images. For quantification, a single representative slice for each z-stack was used to avoid the complication of mitochondria being present in two planes. This slice was made binary using the Nikon Elements thresholding tool. First, a background subtraction of a constant 50 was applied. A threshold for the GFP signal was determined by applying the average threshold for mask creation of control images and was applied to all images. Mitochondrial circularity, number, and area were measured using the measure objects tool in Nikon Elements after the threshold was applied. For mitochondrial circularity, raw numbers were exported to Microsoft Excel and averages were calculated prior to statistical analysis in Graphpad. All other calculations were exported directly to Graphpad for analysis.

Statistical analysis

All data was found to be parametic, following a normal distribution. Homoschedasticity was confirmed using Bartlett’s test. Survival plots were compared using the log-rank test. For analyses involving multiple groups, either a one way ANOVA or two way ANOVA was used to assess significance followed by a Bonferroni post-hoc test for detecting specific differences between groups. For lifespan assays, we completed three replicates with 40 worms per replicate. For brood size assays, we completed three replicates with 5 worms per replicate. For post-embryonic development time assays, we completed three replicates with 25 worms per replicate. For defecation assays, we completed three replicates with 5–10 worms per replicate. For thrashing assays, we completed three replicates with 50 worms per replicate. For crawling speed assays, we completed three replicates with 10 worms per replicate. For ethanol avoidance assays, we completed eight replicates with 50 worms per replicate. For basal slowing assays, we completed three replicates with 10 worms per replicate. For dopamine neurodegeneration assays, we performed three replicates with a minimum of 10 different animals per time point. For mitochondrial morphology assays, we completed three replicates with 3–5 worms per replicate. For oxygen consumption assays, we completed at least 10 replicates using a population of worms for each replicate. For ATP assays, we completed at least three replicates using a population of worms per replicate. For lipofuscin measurement and measurement of Phsp-6::GFP reporter activity, we performed measurements in 10 different animals. For paraquat assays, we completed three replicates with 40 worms per replicate. For osmotic stress and heat stress assays, we completed six replicates with 25 worms per replicate.

Additional information

Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  1. 1.

    Schapira, A. H. et al. Mitochondrial complex I deficiency in Parkinson’s disease. Journal of neurochemistry 54, 823–827 (1990).

  2. 2.

    Langston, J. W., Ballard, P., Tetrud, J. W. & Irwin, I. Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis. Science 219, 979–980, https://doi.org/10.1126/science.6823561 (1983).

  3. 3.

    Testa, C. M., Sherer, T. B. & Greenamyre, J. T. Rotenone induces oxidative stress and dopaminergic neuron damage in organotypic substantia nigra cultures. Mol Brain Res 134, 109–118, https://doi.org/10.1016/j.molbrainres.2004.11.007 (2005).

  4. 4.

    Tieu, K. A Guide to Neurotoxic Animal Models of Parkinson’s Disease. Csh Perspect Med 1, doi:ARTN a00931610.1101/cshperspect.a009316 (2011).

  5. 5.

    Cookson, M. R. Parkinsonism Due to Mutations in PINK1, Parkin, and DJ-1 and Oxidative Stress and Mitochondrial Pathways. Csh Perspect Med 2, doi:ARTN a00941510.1101/cshperspect.a009415 (2012).

  6. 6.

    Christine Klein, A. W. Genetics of Parkinson’s Disease. Cold Spring Harbor Press 1, 49–65 (2012).

  7. 7.

    Valente, E. M. et al. Hereditary early-onset Parkinson’s disease caused by mutations in PINK1. Science 304, 1158–1160, https://doi.org/10.1126/science.1096284 (2004).

  8. 8.

    Kitada, T. et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392, 605–608, https://doi.org/10.1038/33416 (1998).

  9. 9.

    Bonifati, V. et al. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299, 256–259, https://doi.org/10.1126/science.1077209 (2003).

  10. 10.

    Chan, N. C. et al. Broad activation of the ubiquitin-proteasome system by Parkin is critical for mitophagy. Human molecular genetics 20, 1726–1737, https://doi.org/10.1093/hmg/ddr048 (2011).

  11. 11.

    Sarraf, S. A. et al. Landscape of the PARKIN-dependent ubiquitylome in response to mitochondrial depolarization. Nature 496, 372−+, https://doi.org/10.1038/nature12043 (2013).

  12. 12.

    Narendra, D., Tanaka, A., Suen, D. F. & Youle, R. J. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J Cell Biol 183, 795–803, https://doi.org/10.1083/jcb.200809125 (2008).

  13. 13.

    Deas, E., Wood, N. W. & Plun-Favreau, H. Mitophagy and Parkinson’s disease: the PINK1-parkin link. Biochimica et biophysica acta 1813, 623–633, https://doi.org/10.1016/j.bbamcr.2010.08.007 (2011).

  14. 14.

    Narendra, D. P. et al. PINK1 Is Selectively Stabilized on Impaired Mitochondria to Activate Parkin. Plos Biol 8, doi:ARTN e100029810.1371/journal.pbio.1000298 (2010).

  15. 15.

    Vincow, E. S. et al. The PINK1-Parkin pathway promotes both mitophagy and selective respiratory chain turnover in vivo. Proceedings of the National Academy of Sciences of the United States of America 110, 6400–6405, https://doi.org/10.1073/pnas.1221132110 (2013).

  16. 16.

    Pickrell, A. M. & Youle, R. J. The Roles of PINK1, Parkin, and Mitochondrial Fidelity in Parkinson’s Disease. Neuron 85, 257–273, https://doi.org/10.1016/j.neuron.2014.12.007 (2015).

  17. 17.

    Lazarou, M. et al. The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy. Nature 524, 309–314, https://doi.org/10.1038/nature14893 (2015).

  18. 18.

    Andres-Mateos, E. et al. DJ-1 gene deletion reveals that DJ-1 is an atypical peroxiredoxin-like peroxidase. Proceedings of the National Academy of Sciences of the United States of America 104, 14807–14812, https://doi.org/10.1073/pnas.0703219104 (2007).

  19. 19.

    Shendelman, S., Jonason, A., Martinat, C., Leete, T. & Abeliovich, A. DJ-1 is a redox-dependent molecular chaperone that inhibits alpha-synuclein aggregate formation. PLoS biology 2, e362, https://doi.org/10.1371/journal.pbio.0020362 (2004).

  20. 20.

    Martinat, C. et al. Sensitivity to oxidative stress in DJ-1-deficient dopamine neurons: an ES- derived cell model of primary Parkinsonism. PLoS biology 2, e327, https://doi.org/10.1371/journal.pbio.0020327 (2004).

  21. 21.

    Zhang, L. et al. Mitochondrial localization of the Parkinson’s disease related protein DJ-1: implications for pathogenesis. Human molecular genetics 14, 2063–2073, https://doi.org/10.1093/hmg/ddi211 (2005).

  22. 22.

    Chen, P. et al. Age- and manganese-dependent modulation of dopaminergic phenotypes in a C-elegans DJ-1 genetic model of Parkinson’s disease. Metallomics 7, 289–298, https://doi.org/10.1039/c4mt00292j (2015).

  23. 23.

    Xiong, H. et al. Parkin, PINK1, and DJ-1 form a ubiquitin E3 ligase complex promoting unfolded protein degradation. J Clin Invest 119, 650–660, https://doi.org/10.1172/JCI37617 (2009).

  24. 24.

    Rolland, S. G. et al. Impaired complex IV activity in response to loss of LRPPRC function can be compensated by mitochondrial hyperfusion. Proc Natl Acad Sci USA, https://doi.org/10.1073/pnas.1303872110 (2013).

  25. 25.

    Chen, H., Chomyn, A. & Chan, D. C. Disruption of fusion results in mitochondrial heterogeneity and dysfunction. The Journal of biological chemistry 280, 26185–26192, https://doi.org/10.1074/jbc.M503062200 (2005).

  26. 26.

    Liesa, M. & Shirihai, O. S. Mitochondrial dynamics in the regulation of nutrient utilization and energy expenditure. Cell metabolism 17, 491–506, https://doi.org/10.1016/j.cmet.2013.03.002 (2013).

  27. 27.

    Thomas, K. J. et al. DJ-1 acts in parallel to the PINK1/parkin pathway to control mitochondrial function and autophagy. Hum Mol Genet 20, 40–50, https://doi.org/10.1093/hmg/ddq430 (2011).

  28. 28.

    Back, P. et al. Exploring real-time in vivo redox biology of developing and aging Caenorhabditis elegans. Free radical biology & medicine 52, 850–859, https://doi.org/10.1016/j.freeradbiomed.2011.11.037 (2012).

  29. 29.

    Hosokawa, H. et al. Rapid accumulation of fluorescent material with aging in an oxygen-sensitive mutant mev-1 of Caenorhabditis elegans. Mechanisms of ageing and development 74, 161–170 (1994).

  30. 30.

    Morsci, N. S., Hall, D. H., Driscoll, M. & Sheng, Z. H. Age-Related Phasic Patterns of Mitochondrial Maintenance in Adult Caenorhabditis elegans Neurons. J Neurosci 36, 1373–1385, https://doi.org/10.1523/JNEUROSCI.2799-15.2016 (2016).

  31. 31.

    Yoneda, T. et al. Compartment-specific perturbation of protein handling activates genes encoding mitochondrial chaperones. Journal of cell science 117, 4055–4066, https://doi.org/10.1242/jcs.01275 (2004).

  32. 32.

    Nargund, A. M., Pellegrino, M. W., Fiorese, C. J., Baker, B. M. & Haynes, C. M. Mitochondrial import efficiency of ATFS-1 regulates mitochondrial UPR activation. Science 337, 587–590, https://doi.org/10.1126/science.1223560 (2012).

  33. 33.

    Tenreiro, S., Franssens, V., Winderickx, J. & Outeiro, T. F. Yeast models of Parkinson’s disease-associated molecular pathologies. Current opinion in genetics & development 44, 74–83, https://doi.org/10.1016/j.gde.2017.01.013 (2017).

  34. 34.

    Ved, R. et al. Similar patterns of mitochondrial vulnerability and rescue induced by genetic modification of alpha-synuclein, parkin, and DJ-1 in Caenorhabditis elegans. The Journal of biological chemistry 280, 42655–42668, https://doi.org/10.1074/jbc.M505910200 (2005).

  35. 35.

    Kirienko, N. V., Ausubel, F. M. & Ruvkun, G. Mitophagy confers resistance to siderophore-mediated killing by Pseudomonas aeruginosa. Proceedings of the National Academy of Sciences of the United States of America 112, 1821–1826, https://doi.org/10.1073/pnas.1424954112 (2015).

  36. 36.

    Palikaras, K., Lionaki, E. & Tavernarakis, N. Coordination of mitophagy and mitochondrial biogenesis during ageing in C. elegans. Nature 521, 525–528, https://doi.org/10.1038/nature14300 (2015).

  37. 37.

    Chakraborty, S. et al. Loss of pdr-1/parkin influences Mn homeostasis through altered ferroportin expression in C. elegans. Metallomics: integrated biometal science 7, 847–856, https://doi.org/10.1039/c5mt00052a (2015).

  38. 38.

    Martinez, B. A., Kim, H., Ray, A., Caldwell, G. A. & Caldwell, K. A. A bacterial metabolite induces glutathione-tractable proteostatic damage, proteasomal disturbances, and PINK1-dependent autophagy in C. elegans. Cell death & disease 6, e1908, https://doi.org/10.1038/cddis.2015.270 (2015).

  39. 39.

    Dusonchet, J. et al. A Parkinson’s disease gene regulatory network identifies the signaling protein RGS2 as a modulator of LRRK2 activity and neuronal toxicity. Human molecular genetics 23, 4887–4905, https://doi.org/10.1093/hmg/ddu202 (2014).

  40. 40.

    Samann, J. et al. Caenorhabditits elegans LRK-1 and PINK-1 act antagonistically in stress response and neurite outgrowth. The Journal of biological chemistry 284, 16482–16491, https://doi.org/10.1074/jbc.M808255200 (2009).

  41. 41.

    Lee, J. Y. et al. Human DJ-1 and its homologs are novel glyoxalases. Human molecular genetics 21, 3215–3225, https://doi.org/10.1093/hmg/dds155 (2012).

  42. 42.

    Venderova, K. et al. Leucine-Rich Repeat Kinase 2 interacts with Parkin, DJ-1 and PINK-1 in a Drosophila melanogaster model of Parkinson’s disease. Hum Mol Genet 18, 4390–4404, https://doi.org/10.1093/hmg/ddp394 (2009).

  43. 43.

    van der Merwe, C., Jalali Sefid Dashti, Z., Christoffels, A., Loos, B. & Bardien, S. Evidence for a common biological pathway linking three Parkinson’s disease-causing genes: parkin, PINK1 and DJ-1. The European journal of neuroscience 41, 1113–1125, https://doi.org/10.1111/ejn.12872 (2015).

  44. 44.

    Luz, A. L. et al. Mitochondrial Morphology and Fundamental Parameters of the Mitochondrial Respiratory Chain Are Altered in Caenorhabditis elegans Strains Deficient in Mitochondrial Dynamics and Homeostasis Processes. PLoS One 10, e0130940, https://doi.org/10.1371/journal.pone.0130940 (2015).

  45. 45.

    Gitschlag, B. L. et al. Homeostatic Responses Regulate Selfish Mitochondrial Genome Dynamics in C. elegans. Cell metabolism 24, 91–103, https://doi.org/10.1016/j.cmet.2016.06.008 (2016).

  46. 46.

    Lin, Y. F. et al. Maintenance and propagation of a deleterious mitochondrial genome by the mitochondrial unfolded protein response. Nature 533, 416–419, https://doi.org/10.1038/nature17989 (2016).

  47. 47.

    Valenci, I., Yonai, L., Bar-Yaacov, D., Mishmar, D. & Ben-Zvi, A. Parkin modulates heteroplasmy of truncated mtDNA in Caenorhabditis elegans. Mitochondrion 20, 64–70, https://doi.org/10.1016/j.mito.2014.11.001 (2015).

  48. 48.

    Bess, A. S., Crocker, T. L., Ryde, I. T. & Meyer, J. N. Mitochondrial dynamics and autophagy aid in removal of persistent mitochondrial DNA damage in Caenorhabditis elegans. Nucleic acids research 40, 7916–7931, https://doi.org/10.1093/nar/gks532 (2012).

  49. 49.

    Cooper, J. F. et al. Delaying aging is neuroprotective in Parkinson’s disease: a genetic analysis in C. elegans models. Nature partner journal Parkinson’s Disease 1, 15022 (2015).

  50. 50.

    Van Raamsdonk, J. M. & Hekimi, S. FUdR causes a twofold increase in the lifespan of the mitochondrial mutant gas-1. Mech Ageing Dev 132, 519–521, https://doi.org/10.1016/j.mad.2011.08.006 (2011).

  51. 51.

    Dues, D. J. et al. Aging causes decreased resistance to multiple stresses and a failure to activate specific stress response pathways. Aging (Albany NY) 8, 777–795, https://doi.org/10.18632/aging.100939 (2016).

  52. 52.

    Schaar, C. E. et al. Mitochondrial and cytoplasmic ROS have opposing effects on lifespan. PLoS Genet 11, e1004972, https://doi.org/10.1371/journal.pgen.1004972 (2015).

  53. 53.

    Machiela, E., Dues, D. J., Senchuk, M. M. & Van Raamsdonk, J. M. Oxidative stress is increased in C. elegans models of Huntington’s disease but does not contribute to polyglutamine toxicity phenotypes. Neurobiology of disease 96, 1–11, https://doi.org/10.1016/j.nbd.2016.08.008 (2016).

  54. 54.

    Dues, D. J. et al. Uncoupling of oxidative stress resistance and lifespan in long-lived isp-1 mitochondrial mutants in Caenorhabditis elegans. Free radical biology & medicine 108, 362–373, https://doi.org/10.1016/j.freeradbiomed.2017.04.004 (2017).

Download references

Acknowledgements

This work was supported by the National Institute on Aging (NIA) by grant number R21 AG058241 (PI: Jeremy Van Raamsdonk), the National Institute of General Medical Sciences (NIGMS) by grant number R01 GM121756 (PI: Jeremy Van Raamsdonk) and the Van Andel Research Institute (VARI). We would like to thank Zach Madaj in the Van Andel Research Institute Bioinformatics and Biostatistics Core for assistance with statistical analysis. Some strains were provided by the CGC, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440). We would also like to acknowledge the C. elegans knockout consortium and the National Bioresource Project of Japan for providing strains used in this research.

Author information

Affiliations

  1. Laboratory of Aging and Neurodegenerative Disease, Center for Neurodegenerative Science, Van Andel Research Institute, Grand Rapids, MI, USA

    • Jason F. Cooper
    • , Emily Machiela
    • , Dylan J. Dues
    • , Katie K. Spielbauer
    • , Megan M. Senchuk
    •  & Jeremy M. Van Raamsdonk
  2. Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada

    • Jeremy M. Van Raamsdonk
  3. Metabolic Disorders and Complications Program, and Brain Repair and Integrative Neuroscience Program, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada

    • Jeremy M. Van Raamsdonk

Authors

  1. Search for Jason F. Cooper in:

  2. Search for Emily Machiela in:

  3. Search for Dylan J. Dues in:

  4. Search for Katie K. Spielbauer in:

  5. Search for Megan M. Senchuk in:

  6. Search for Jeremy M. Van Raamsdonk in:

Contributions

Conceptualization, J.V.R., J.F.C. and E.M.; Methodology, J.F.C., E.M., D.J.D., K.K.S., M.M.S. and J.V.R.; Validation, J.V.R.; Formal Analysis, J.F.C., E.M., M.M.S. and J.V.R.; Investigation, J.F.C., E.M., D.J.D., K.K.S., M.M.S. and J.V.R.; Writing – original draft, J.F.C. and J.V.R.; Writing – reviewing and editing, J.F.C., E.M., D.J.D., K.K.S., M.M.S. and J.V.R.; Visualization, J.F.C., E.M., M.M.S. and J.V.R.; Supervision, J.V.R.; Project administration, J.V.R.; Funding Acquisition, J.V.R.

Competing Interests

The authors declare that they have no competing interests.

Corresponding author

Correspondence to Jeremy M. Van Raamsdonk.

Electronic supplementary material

About this article

Publication history

Received

Accepted

Published

DOI

https://doi.org/10.1038/s41598-017-16637-2

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.